FAQs

Show All
Where is Deciphera’s corporate headquarters located?
Deciphera Pharmaceuticals is headquartered at 200 Smith Street, Waltham, MA 02451, U.S.

The main phone number is (781) 209-6400.
How is Deciphera’s stock traded?
Deciphera is traded on the NASDAQ global stock exchange under the ticker symbol DCPH, and the CUSIP number for the common stock is 24344T101.
When did Deciphera’s go public?
Deciphera’s initial public offering (IPO) occurred on October 2, 2017.
When is Deciphera’s fiscal year-end?
Deciphera will end the fiscal year on December 31st.
Who is Deciphera’s transfer agent?
Communication regarding transfer requirements, lost certificates and changes of address should be directed to:

Computershare Trust Company, N.A.
(877) 373-6374 (Toll-free)
(781) 575 3100 (International)
https://www.computershare.com/us/investor-inquiries

If delivering by mail:

Computershare Trust Company Operations Center
P.O. Box 43078
Providence, RI 02940-3078
United States
Who are Deciphera’s independent auditors?
PricewaterhouseCoopers LLP
101 Seaport Boulevard
Boston, MA 02110
+1 617 530 5000
Where can I view Deciphera’s latest corporate news releases?
Deciphera’s press release archives can be viewed here.
How can I view documents that Deciphera has filed with the Securities & Exchange Commission (SEC), including Forms 10-K and 10-Q?
Deciphera’s SEC filings can be viewed at here or at www.sec.gov.
Whom should I contact if I have further questions?
You can submit queries to Deciphera’s Investor Relations department by contacting investors@deciphera.com